HPR86 Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.810
https://www.valueinhealthjournal.com/article/S1098-3015(25)00935-0/fulltext
Title :
HPR86 Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)00935-0&doi=10.1016/j.jval.2025.04.810
First page :
Section Title :
Open access? :
No
Section Order :
10527